Boston Scientific introduces flexible hemostatic clip

A new hemostatic clipping device will soon enter the market as a technology designed to give physicians more control when placing clips on a patient’s gastrointestinal tract.

The Resolution 360 Clip, designed by Boston Scientific, will be introduced at the annual United Europeans Gastroenterology Week in Vienna, Austria, and then again at the American College of Gastroenterology in Las Vegas. Physicians who attend the meetings will have a chance to use the device in a simulator, Boston Scientific said in a statement.

The clip can be used in several endoscopy procedures of the upper and lower gastrointestinal tract. It’s designed to stop and prevent bleeding stemming from peptic ulcers, polyps removed during a colonoscopy and diverticulosis of the colon.

"The Resolution 360 Clip gives me the unique advantage of controlling the movement and placement of the clip while also maneuvering the scope during the clipping procedure," said David L. Carr-Locke, MD, chief of digestive diseases at Mount Sinai Beth Israel Medical Center in New York, in a statement. "The ability to have complete control can help improve the accuracy of clip placement and the speed of the procedure particularly in complex cases."

The Resolution 360 Clip is constructed with a multi-wire braided catheter, which lets a doctor rotate the device in small, controlled movements that will prevent bleeding.

"We are always striving to improve our technology so that physicians have the tools they need to diagnose and treat gastrointestinal disease more easily and effectively," said Art Butcher, senior vice president and president of endoscopy at Boston Scientific, in a statement. "Building on the legacy Resolution Clip and its clinically proven technology, the expanded portfolio now offers physicians more hemostatic clipping options to consider in different clinical situations and patient anatomies."

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.